These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36620013)

  • 1. Outer membrane vesicles: A bacterial-derived vaccination system.
    Lieberman LA
    Front Microbiol; 2022; 13():1029146. PubMed ID: 36620013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
    Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
    Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
    Lei EK; Azmat A; Henry KA; Hussack G
    Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineering bacterial outer membrane vesicles as vaccine platform.
    Gerritzen MJH; Martens DE; Wijffels RH; van der Pol L; Stork M
    Biotechnol Adv; 2017 Sep; 35(5):565-574. PubMed ID: 28522212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer Membrane Vesicle Vaccine Platforms.
    Micoli F; Adamo R; Nakakana U
    BioDrugs; 2024 Jan; 38(1):47-59. PubMed ID: 37796436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
    Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial outer membrane vesicles as potential biological nanomaterials for antibacterial therapy.
    Huang W; Meng L; Chen Y; Dong Z; Peng Q
    Acta Biomater; 2022 Mar; 140():102-115. PubMed ID: 34896632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gram-negative outer membrane vesicles in vaccine development.
    Collins BS
    Discov Med; 2011 Jul; 12(62):7-15. PubMed ID: 21794204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial Outer Membrane Vesicles as Antibiotic Delivery Vehicles.
    Collins SM; Brown AC
    Front Immunol; 2021; 12():733064. PubMed ID: 34616401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial Outer Membrane Vesicles: Role in Pathogenesis and Host-Cell Interactions.
    Magaña G; Harvey C; Taggart CC; Rodgers AM
    Antibiotics (Basel); 2023 Dec; 13(1):. PubMed ID: 38247591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoengineered Outer Membrane Vesicles as a Platform for Vaccine Development.
    Valguarnera E; Feldman MF
    Methods Enzymol; 2017; 597():285-310. PubMed ID: 28935107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A basis for vaccine development: Comparative characterization of Haemophilus influenzae outer membrane vesicles.
    Roier S; Blume T; Klug L; Wagner GE; Elhenawy W; Zangger K; Prassl R; Reidl J; Daum G; Feldman MF; Schild S
    Int J Med Microbiol; 2015 May; 305(3):298-309. PubMed ID: 25592265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and proteomic analysis of outer membrane vesicles from a commensal microbe, Enterobacter cloacae.
    Bhar S; Edelmann MJ; Jones MK
    J Proteomics; 2021 Jan; 231():103994. PubMed ID: 33007464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outer membrane vesicles (OMVs) enabled bio-applications: A critical review.
    Huang Y; Nieh MP; Chen W; Lei Y
    Biotechnol Bioeng; 2022 Jan; 119(1):34-47. PubMed ID: 34698385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
    Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
    Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
    Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.
    Gerritzen MJH; Maas RHW; van den Ijssel J; van Keulen L; Martens DE; Wijffels RH; Stork M
    Microb Cell Fact; 2018 Oct; 17(1):157. PubMed ID: 30285743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer Membrane Vesicle Induction and Isolation for Vaccine Development.
    Balhuizen MD; Veldhuizen EJA; Haagsman HP
    Front Microbiol; 2021; 12():629090. PubMed ID: 33613498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
    Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
    Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.